What is UFP Technologies Inc?
designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
UFPT · Verdict
Solid reward · moderate risk
UFPT scores well on cash flow and growth with no major weaknesses flagged in the model.
Based on 88% data coverage
UFPT · Verdict
13% free-cash-flow margin
Rev +19.4% CAGR · earnings +17.8%
Model-based scoring. For information only — not financial advice.
designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company offers protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.62B, and a P/E ratio of 24.5x.
The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.